Governance Pharmaron Beijing Co., Ltd.

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-23			5-day change	1st Jan Change
31.11 ^CNY	-0.61%		-5.09%	+9.43%

06:21am	CMB International Starts Pharmaron Beijing at Buy with 38.08 Yuan Price Target	MT
Jan. 22	Pharmaron Beijing Completes HK$1.32 Billion Share Offering	MT

Executive Committee: Pharmaron Beijing Co., Ltd.

Manager

Positions heldSince

Bo Liang Lou

62 year

Chief Executive Officer	2016-10-26
Founder	2004-06-30

Wei Tang

General Counsel

2017-06-30

Hua Yang

64 year

Chief Tech/Sci/R&D Officer

2016-10-26

Celina Zhong

Human Resources Officer

2011-12-31

Xiao Qiang Lou

57 year

Chief Operating Officer	2016-10-26
Founder	2004-06-30
President	-

Composition of the Board of Directors: Pharmaron Beijing Co., Ltd.

Director

CommitteesSince

Bo Liang Lou

62 year

Compensation Committee	2016-10-26
Nominating Committee	2016-10-26

Li Hua Li

62 year

Audit Committee	2022-09-22
Compensation Committee Chair	2022-09-22
Nominating Committee Chair	2022-09-22

Jian Yu

52 year

Audit Committee
Compensation Committee
Nominating Committee

Bei Zheng

59 year

Nominating Committee

2016-10-26

Xiao Qiang Lou

57 year

Compensation Committee

2016-10-26

Jia Qing Li

53 year

Audit Committee

2021-05-25

Ke Xin Yang

64 year

Chairman

2016-10-26

Lan Zhang

44 year

Director/Board Member

2016-10-26

Shu Feng

41 year

Director/Board Member

2020-12-10

Latest Appointments: Pharmaron Beijing Co., Ltd.

Dec. 18	Pharmaron Beijing Co., Ltd. Announces Election of Mr. Li Shing Chung Gilbert as Employee Representative Director Effective December 18, 2025	CI
25-10-28	Pharmaron Beijing Co., Ltd. Announces Resignation of Tsang Kwan Hung Benson as Independent Non-Executive Director	CI
25-04-27	Pharmaron Beijing Co., Ltd. Announces Resignation of Hu Baifeng as Non-Executive Director and A Member of the Strategy Committee	CI
24-04-25	Pharmaron Beijing Co., Ltd. Announces Executive Changes	CI
22-09-23	Pharmaron Beijing Co., Ltd. Announces Board Appointments	CI
22-08-29	Pharmaron Beijing Co., Ltd. Announces Board Changes	CI
22-01-16	Pharmaron Beijing Co., Ltd. Announces Executive Changes	CI

More news

Former Officers and Directors: Pharmaron Beijing Co., Ltd.

Insider

Positions held

SinceUntil

Kwan Hung Tsang

Director/Board Member	2019-08-14	2025-12-17
Independent Dir/Board Member	2019-08-14	2025-12-17

Bai Feng Hu

Director/Board Member

2017-10-12

2025-06-19

Qi Lin Zhou

Director/Board Member	2022-09-22	2024-11-26
Independent Dir/Board Member	2022-09-22	2024-11-26

Lok Kwan Yim

Corporate Secretary

2024-04-24

Hong Bin Zhou

Director/Board Member

2016-10-26

2023-06-20

Baifeng Hu

Director/Board Member

2023-06-20

Ping Jin Chen

Director/Board Member

2017-10-12

2023-06-20

Guo Qin Chen

Director/Board Member	2016-10-26	2022-09-22
Independent Dir/Board Member	2016-10-26	2022-09-22

Li Xin Dai

Director/Board Member	2016-10-26	2022-09-22
Independent Dir/Board Member	2016-10-26	2022-09-22

Sid Bhoopathy

Corporate Officer/Principal

2021-10-31

Jun Liu

Director/Board Member

2017-10-12

2020-12-10

Rong Shen

Director/Board Member	2016-10-26	2020-07-22
Independent Dir/Board Member	2016-10-26	2020-07-22

Cheng Zong Li

Director of Finance/CFO	2016-10-26	2019-08-27
Investor Relations Contact	-	2019-08-27
Corporate Secretary	2016-10-26	2019-08-27

Anthony Partridge

Corporate Officer/Principal

2011-08-31

2014-05-31

Chang Qing Cao

Corporate Officer/Principal

2011-10-31

2013-08-31

Jim Zhu

Corporate Officer/Principal

2013-03-31

Shi-Yi Yue

Corporate Officer/Principal

2011-12-31

Wu Yang

Corporate Officer/Principal

2011-06-30

Ziping Liu

Corporate Officer/Principal

2011-05-31

Xiao Hui Gu

Corporate Officer/Principal

2011-04-30

Nobuo Shimma

Chief Tech/Sci/R&D Officer	2011-03-31	2014-09-14
Corporate Officer/Principal	2014-09-14	-

Dalei Shao

Corporate Officer/Principal

2011-03-31

Allen Jiang

Corporate Officer/Principal

2010-12-31

Xinyi Huang

Corporate Officer/Principal

2010-03-31

Rongshi Li

Corporate Officer/Principal

2007-06-30

2008-07-31

Richard Li

Director of Finance/CFO

2009-10-13

Wenfang Miao

Corporate Officer/Principal

2007-12-31

Chang Bai

Corporate Officer/Principal

2007-12-31

Yan Li Zhou

Comptroller/Controller/Auditor	2009-10-15	-
Corporate Officer/Principal	2009-10-13	2009-10-15

Ming Hong Sui

Human Resources Officer

2005-03-31

Zhixian You

Corporate Officer/Principal

2009-10-13

William You

Corporate Officer/Principal

2003-12-31

Nan Zheng

Chief Administrative Officer

2003-12-31

Wangsheng Luo

Corporate Officer/Principal

2009-10-13

Changwei Mu

Corporate Officer/Principal

2003-12-31

Hong Xu

Corporate Officer/Principal

2009-10-13

Xin He Lin

Director/Board Member

Jingqi Huang

Corporate Officer/Principal

Cordia Lau

Comptroller/Controller/Auditor

Guosheng Wu

Corporate Officer/Principal

Charles Liu

Corporate Officer/Principal

Zhongren Wu

Corporate Officer/Principal

Ronald J. Marler

Director/Board Member

Xing Cheng

Corporate Officer/Principal

Stephanie Taulbee

Corporate Officer/Principal

Tina Huang

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	21
Female	6

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	5
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (61.3%); - development and production of chemical processes and formulations (23.5%); - clinical research services (12.8%); - other (2.4%); Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).

Employees

21,370

Sector

Biotechnology & Medical Research

Calendar

Mar. 29 - Q4 2025 Earnings Release (Projected)

More about the company